Bausch Health Companies | Deudores Comerciales

Precio De Mercado
7.82
Cambio Diario
-0.32 -3.93%
Mensual
0.64%
Anual
-22.96%
Q1 Expectativa
7.89




Deudores Comerciales Cambio Fecha
Amgen USD 9.57B 1.08B 2025-12
ANI Pharmaceuticals USD 281.08M 28.46M 2025-12
Aurora Cannabis CAD 46.73M 7.59M 2025-09
Bausch Health Companies USD 2.35B 66M 2025-12
Biogen USD 1.85B 234M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 26.86M 23.17M 2025-09
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Danaher USD 3.91B 762M 2025-12
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Novo Nordisk DKK 95.05B 2.4B 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Phibro Animal Health USD 160.78M 8.67M 2024-09
Prestige Brands USD 190.46M 8.54M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Zoetis USD 1.59B 49M 2025-12


Bausch Health Companies Deudores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.